SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a - 16 OR 15d - 16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of September, 2005
SkyePharma PLC
SkyePharma PLC, 105 Piccadilly, London W1J 7NJ England
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40F.
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _______
For immediate release 30 September 2005
SkyePharma PLC ("the Company")
Notification of Interests of Directors
The Company was informed on 29 September 2005 by Ian Gowrie-Smith, Non-executive Chairman of SkyePharma PLC, that on 29 September
2005 Thornaby Limited, a company in which he has a beneficial interest, purchased 500,000 Ordinary Shares in the Company at a
price of 38.75 pence per share. The shares are registered in the name of J M Finn Nominees. As a result of the transaction
Mr Gowrie-Smith now has a beneficial interest in 7,121,038 Ordinary Shares in the Company.
The Company was informed on 29 September 2005 by Donald Nicholson, Finance Director of SkyePharma PLC, that on 29 September
2005 he purchased 150,000 Ordinary Shares in the Company at a price of 39.25 pence per share. As a result of the transaction
Mr Nicholson now has a beneficial interest in 541,361 Ordinary Shares in the Company.
- ends -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SkyePharma PLC
By: /s/ Douglas Parkhill
Name: Douglas Parkhill
Title:
Company Secretary
Date: September 30, 2005